Angiogenesis-Related Biomarkers (sFlt-1/PLGF) in the Prediction and Diagnosis of Placental Dysfunction: An Approach for Clinical Integration
Placental dysfunction is involved in a group of obstetrical conditions including preeclampsia, intrauterine growth restriction, and placental abruption. Their timely and accurate recognition is often a challenge since diagnostic criteria are still based on nonspecific signs and symptoms. The discove...
Main Authors: | Herraiz, Ignacio, Simón, Elisa, Gómez-Arriaga, Paula Isabel, Martínez-Moratalla, José Manuel, García-Burguillo, Antonio, López Jiménez, Elena Ana, Galindo, Alberto |
---|---|
Format: | Online |
Language: | English |
Published: |
MDPI
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581283/ |
Similar Items
-
PlGF/sFlt‑1 as Early Detection Biomarker for Preeclampsia
by: Rano K. Sinuraya, et al.
Published: (2017-06-01) -
Difference of concentration of placental soluble fms-like tyrosine kinase-1(sFlt-1), placental growth factor (PlGF), and sFlt-1/PlGF ratio in severe preeclampsia and normal pregnancy
by: Gurnadi, Jeffry Iman, et al.
Published: (2015) -
Implementation of the sFlt-1/PlGF ratio for prediction and diagnosis of pre-eclampsia in singleton pregnancy: implications for clinical practice
by: Stepan, H, et al.
Published: (2015) -
Economic assessment of the use of the sFlt-1/PlGF ratio test to predict preeclampsia in Germany
by: Dietmar Schlembach, et al.
Published: (2018-08-01) -
Influence of the sFlt-1/PlGF Ratio on Clinical Decision-Making in Women with Suspected Preeclampsia
by: Klein, Evelyn, et al.
Published: (2016)